Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 949845, 10 pages
http://dx.doi.org/10.1155/2014/949845
Research Article

Murine Aortic Smooth Muscle Cells Acquire, Though Fail to Present Exogenous Protein Antigens on Major Histocompatibility Complex Class II Molecules

1Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy
2Centre for Immunobiology, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, 120 University Place, Glasgow G12 8TA, UK
3Novartis Vaccines, Via Fiorentina 1, 53100 Siena, Italy

Received 28 March 2014; Accepted 11 June 2014; Published 20 July 2014

Academic Editor: Grant Drummond

Copyright © 2014 Marcella Maddaluno et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Galkina and K. Ley, “Immune and inflammatory mechanisms of atherosclerosis,” Annual Review of Immunology, vol. 27, pp. 165–197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Libby, A. Lichtman, and G. Hansson, “Immune effector mechanisms implicated in atherosclerosis: from mice to humans,” Immunity, vol. 38, no. 6, pp. 1092–1104, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. G. K. Owens, M. S. Kumar, and B. R. Wamhoff, “Molecular regulation of vascular smooth muscle cell differentiation in development and disease,” Physiological Reviews, vol. 84, no. 3, pp. 767–801, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. A. C. Doran, N. Meller, and C. A. McNamara, “Role of smooth muscle cells in the initiation and early progression of atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 5, pp. 812–819, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Allahverdian, P. S. Pannu, and G. A. Francis, “Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation,” Cardiovascular Research, vol. 95, no. 2, pp. 165–172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Loppnow, M. Buerke, K. Werdan, and S. Rose-John, “Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis,” Journal of Cellular and Molecular Medicine, vol. 15, no. 3, pp. 484–500, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Lötzer, S. Döpping, S. Connert et al., “Mouse aorta smooth muscle cells differentiate into lymphoid tissue organizer-like cells on combined tumor necrosis factor receptor-1/lymphotoxin β-receptor NF-κB Signaling,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 3, pp. 395–402, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. G. K. Hansson, L. Jonasson, J. Holm, and L. Claesson-Welsh, “Class II MHC antigen expression in the atheroscerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain,” Clinical and Experimental Immunology, vol. 64, no. 2, pp. 261–268, 1986. View at Google Scholar · View at Scopus
  9. S. J. C. Warner, G. B. Friedman, and P. Libby, “Regulation of major histocompatibility gene expression in human vascular smooth muscle cells,” Arteriosclerosis, vol. 9, no. 3, pp. 279–288, 1989. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Stemme, G. Fager, and G. K. Hansson, “MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin,” Immunology, vol. 69, no. 2, pp. 243–249, 1990. View at Google Scholar · View at Scopus
  11. G. Butticè, J. Miller, L. Wang, and B. D. Smith, “Interferon-γ induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells,” Circulation Research, vol. 98, no. 4, pp. 472–479, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Jonasson, J. Holm, and G. K. Hansson, “Smooth muscle cells express Ia antigens during arterial response to injury,” Laboratory Investigation, vol. 58, no. 3, pp. 310–315, 1988. View at Google Scholar · View at Scopus
  13. Z. Fabry, M. M. Waldschmidt, L. Van Dyk, S. A. Moore, and M. N. Hart, “Activation of CD4+ lymphocytes by syngeneic brain microvascular smooth muscle cells,” Journal of Immunology, vol. 145, no. 4, pp. 1099–1104, 1990. View at Google Scholar · View at Scopus
  14. Z. Fabry, M. M. Waldschmidt, S. A. Moore, and M. N. Hart, “Antigen presentation by brain microvessel smooth muscle and endothelium,” Journal of Neuroimmunology, vol. 28, no. 1, pp. 63–71, 1990. View at Publisher · View at Google Scholar · View at Scopus
  15. Z. Fabry, M. Sandor, T. F. Gajewski et al., “Differential activation of Th1 and Th2 CD4+ cells by murine brain microvessel endothelial cells and smooth muscle/pericytes,” Journal of Immunology, vol. 151, no. 1, pp. 38–47, 1993. View at Google Scholar · View at Scopus
  16. B. J. Swanson, D. C. Baiu, M. Sandor, Z. Fabry, and M. N. Hart, “A small population of vasculitogenic T cells expands and has skewed T cell receptor usage after culture with syngeneic smooth muscle cells,” Journal of Autoimmunity, vol. 20, no. 2, pp. 125–133, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Suttles, R. W. Miller, and C. F. Moyer, “T cell-vascular smooth muscle cell interactions: antigen-specific activation and cell cycle blockade of T helper clones by cloned vascular smooth muscle cells,” Experimental Cell Research, vol. 218, no. 1, pp. 331–338, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. A. G. Murray, P. Libby, and J. S. Pober, “Human vascular smooth muscle cells poorly co-stimulate and actively inhibit allogeneic CD4+ T cell proliferation in vitro,” Journal of Immunology, vol. 154, no. 1, pp. 151–161, 1995. View at Google Scholar · View at Scopus
  19. P. Zhang, T. D. Manes, J. S. Pober, and G. Tellides, “Human vascular smooth muscle cells lack essential costimulatory molecules to activate allogeneic memory T cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 9, pp. 1795–1801, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Veler, A. Hu, S. Fatma et al., “Superantigen presentation by airway smooth muscle to CD4+ T lymphocytes elicits reciprocal proasthmatic changes in airway function,” The Journal of Immunology, vol. 178, no. 6, pp. 3627–3636, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. A. Itano, S. J. McSorley, R. L. Reinhardt et al., “Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity,” Immunity, vol. 19, no. 1, pp. 47–57, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. K. A. Pape, D. M. Catron, A. A. Itano, and M. K. Jenkins, “The humoral immune response is initiated in lymph nodes by b cells that acquire soluble antigen directly in the follicles,” Immunity, vol. 26, no. 4, pp. 491–502, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. C. M. Rush, T. J. Mitchell, and P. Garside, “A detailed characterisation of the distribution and presentation of DNA vaccine encoded antigen,” Vaccine, vol. 28, no. 6, pp. 1620–1634, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. N. MacRitchie, G. Grassia, S. R. Sabir et al., “Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein e-deficient mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 11, pp. 2569–2579, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Grassia, M. Maddaluno, A. Guglielmotti et al., “The anti-inflammatory agent bindarit inhibits neointima formation in both rats and hyperlipidaemic mice,” Cardiovascular Research, vol. 84, no. 3, pp. 485–493, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Grassia, M. Maddaluno, C. Musilli et al., “The IκB kinase inhibitor nuclear factor-κB essential modulator-binding domain peptide for inhibition of injury-induced neointimal formation,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 12, pp. 2458–2466, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Maddaluno, G. Grassia, M. V. di Lauro et al., “Bindarit inhibits human coronary artery smooth muscle cell proliferation, migration and phenotypic switching,” PLoS ONE, vol. 7, no. 10, Article ID e47464, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. D. M. Underhill, M. Bassetti, A. Rudensky, and A. Aderem, “Dynamic interactions of macrophages with T cells during antigen presentation,” The Journal of Experimental Medicine, vol. 190, no. 12, pp. 1909–1914, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Culshaw, O. R. Millington, J. M. Brewer, and I. B. McInnes, “Murine neutrophils present Class II restricted antigen,” Immunology Letters, vol. 118, no. 1, pp. 49–54, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. T. R. Ghimire, R. A. Benson, P. Garside, and J. M. Brewer, “Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro,” Immunology Letters, vol. 147, no. 1-2, pp. 55–62, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. V. B. Gibson, R. A. Benson, K. J. Bryson et al., “A novel method to allow noninvasive, longitudinal imaging of the murine immune system in vivo,” Blood, vol. 119, no. 11, pp. 2545–2551, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Marrack, C. Hannum, and M. Harris, “Antigen-specific, major histocompatibility complex-restricted T cell receptors,” Immunological Reviews, vol. 76, pp. 131–145, 1983. View at Publisher · View at Google Scholar · View at Scopus